Martin Samuel Bates

Martin Samuel Bates is listed in filings as SVP AND CFO at Celldex Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to Celldex Therapeutics, Inc. (CLDX). The current snapshot covers public activity from Jun 17, 2024 to Jan 6, 2026. Reported amounts are shown as $50.0K to $608.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.